albert cheung hoi yu, ph.d. albert cheung hoi yu, ph.d. professor infectious disease center, peking...
TRANSCRIPT
Albert Cheung Hoi Yu, Ph.D.Albert Cheung Hoi Yu, Ph.D.
ProfessorInfectious Disease Center, Peking University
Professor and Vice-directorNeuroscience Research Institute, Peking University
Chairman and CEO Hai Kang Life Corporation Limited
Beijing Hai Kang DNA Chips Limited
Collaborative Opportunities on Bioinformatics in theDiagnosis of Infectious Diseases:
Our Preparedness in Battle Against Our Preparedness in Battle Against Avian InfluenzaAvian Influenza ??
2nd ASEAN China International Bioinformatics Workshop, April 2008
Avian Influenza (AI) – A Global Threat !
Surveillance–in man & animals Stockpiling and logistics Emergency responses
Public health Community
Public communication Coordination and command
Influenza Pandemic Preparedness Plan
Phases of AlertPhases of AlertWHO ChinaVery similar
6Efficient and sustained
human-to-humantransmission
Pandemic
5Evidence of significant
human-to-humantransmission
4Evidence of increased
human-to-humantransmission
3No or very limitedhuman-to-human
transmission
PandemicAlert
New virus causes human cases
2Higher risk of human cases
1Low risk of
human cases
Inter-pandemicPhase
New virus inanimals, no
human cases
Pandemic
Efficient and sustained human-to-human transmission OR
WHO announcement of outbreak
I
Human-to-humanTransmissionII
Human infection with no human-to-
human transmissionIII
Preparatory Stage
New virus isolated in humans but triggered no immune response OR immune response
triggered but no symptoms
IV
Degree of R
esponse
Strategy of Strategy of AI AI Control In ChinaControl In ChinaNational Ministry of Public Health
[ With Provincial Departments of Health, Local Health Bureaus ]
Provincial Medical Expert Team
Provincial CDC
Suspected AI Case identified in Local Hospital [by Local Medical Expert Team and Local CDC]
1. Reporting of suspected cases
2. Reporting /
Delivery of sample for diagnosis & confirmation
National Medical Expert Team
4.Communication, feedbacks & proposed response
Direct & Real-time access to medical records through online reporting system
Provide medical expert teams to support diagnosis / treatment National CDC
3. Reporting of confirmed diagnostic result
Cooperation : Diagnosis and Treatment
Surveillance of AI in AnimalsDuring outbreak:
Detection and report of infection by farmers and volunteer, based on clinical criteria (5% deaths in flock), to activate pre-emptive culling, confirmed by lab. (cloacal swab – viral isolation)
After outbreak: Maintenance of clinical-based surveillance with lab.
testing to confirm freedom from disease in control zone around infected area for 21 days, then 5 months (OIE)
Proactive countrywide community survey to detect and destroy infected flocks, then twice a year
Detection and report of all pneumonia & flu-like illnesses with history of exposure to sick/dead poultry or of contact with pneumonia cases…Nasopharyngeal swab of all cases sent for rapid flu test, and conventional test for H5N1. Investigations of all reported cases by trained epidemiology teams. Daily situation monitoring, daily update on website .
Surveillance of AI in Humans
Pandemic Planning Diagnostic Pyramid
AIV Family Tree
• H5N1 viruses in 1997, 2003, 2004 and 2005 are genetically and antigenically different
• Different virus clades encountered in countries of the region:
• Clade 1 (Lao, Thailand, Vietnam, Cambodia, China) • Clade 2-subclade 3 (China, Thailand, Cambodia,
Vietnam)• Clade 2-subclade 1 (Indonesia)
• Sequence variation should be considered in diagnostic development
Evolving Viruses
To defeat an infectious disease, you must control its transmission from infected
people to healthy ones.
The critical issues are planning, surveillance, and getting an early
warning.
It was important to find ways to rapidly tell people that they are not infected.
The Battle Against Infectious Disease
AI in China
Source: BOE, MOPH
Confirmed case
Suspect case
Area of outbreak in poultry
Jan-May 2004 Jun-April 2005
Outbreaks of AI in Poultry and Human Cases in Thailand
May 2005- Dec 05
Lab Conditions
• No temperature control nor heating– temp in lab was about 10oC
• Walls and floors did not have appropriate covering (tiles and bumpy lino)
• Electricity supply not guaranteed (no generator); interruptions experienced during testing
• No freezer below about 8oC
Challenges for Diagnosticsfrom Global Public Health Perspective
As accurate as necessary– to ensure WHO's public health responsibilities fulfilled As quick as possible– to detect the emergence of new variants of human pandemic
potential– to trigger outbreak response, investigation and rapid containment
whenever needed As simple as possible– the majority of diagnostic labs in the world does not have advanced
lab settings– many crucial diagnosis conducted under huge pressure
Current Detection Current Detection MethodsMethods
Ag / Ab-based method
Microbiological evidence of virus (virus isolation)
Conventional PCR
Real time-PCR
NASBA
New MethodNew Method
Modified Enhanced real time-PCR
SymptomsSymptoms
• Respiratory distress syndrome
• X-ray evidence of lung damage
• Fever
VirusVirus
InfectionInfection
UsersUsers
•Where?
•Who? User-friendly?
•Affordable?
Isothermal amplification technique
comparable results within different test units
Simplified operation process
reduced contamination, higher reproducibility
PCR’s false positive result
Amplification Technology of NASBA
Step 3. Probe hybridization
Step 1. Reagent mixing
Step 4. Signal detection by ELISA reader
Step 2. Isothermal incubation (can be replaced by a heat block)
NASBA Protocol
Adapt to regular instrument
NASBA System
Participation of NASBA-EOC Detection in theParticipation of NASBA-EOC Detection in theInfluenza Surveillance Program Influenza Surveillance Program
Commissioned by the National AIV Task ForceCommissioned by the National AIV Task Force
NASBA-EOC: Takes part in the project implemented by National AIV task force
Surveillance of avian influenza virus (generic and subtype H5), human influenza virus, parainfluenza virus, and other selective pneumonia-causing pathogens in Beijing population
Beijing Hai Kang DNA Chips Limited provides NASBA AIV / H5 test kits for the surveillance program
National Task Force for Human AIV
Training on AIV diagnosis using the NASBA EOC method to the National AIV task force members in Beijing, China
Multiplex NASBA!
Molecular Pneumonia Detection SystemsMolecular Pneumonia Detection Systems
Project awarded by the China Ministry of Science and Technology (a “863” project)
We collaborated various hospitals in Beijing including hospitals affiliated Peking University, Chao Yang Hospital, You An Hospital and Di Tan Hospital of Capital Medical University
Development of multiplex NASBA, ERT-PCR and other detection system/ technology for various pneumonia-causing pathogens (including SARS, AIV, influenza, etc.)
Development of a Lab-On-A-Chip (LOAC) system
Was it possible to establish rapid and accurate tests for
Infectious diseases in an outbreak situation?
• Adequate clinical samples• Well characterized samples are
indispensable for the development and evaluation of diagnostic test
• Appropriate and adequate specimens • Good quality• Adequate clinical information• Appropriate labeling and storage • Good data management
Difficulties in Getting Good Diagnostic Kit Validated!
Development of Sustainable and Integrated Management System
Development of Sustainable and Integrated Management System
1. Development of knowledge management mechanism during the inter – pandemic period
2. Development of knowledge management mechanism during pandemic
3. Establishment of a system for coordination and communication among various organizations during pandemic
4. Coordination with foreign and international organizations
5. Monitoring and evaluation
1. Development of knowledge management mechanism during the inter – pandemic period
2. Development of knowledge management mechanism during pandemic
3. Establishment of a system for coordination and communication among various organizations during pandemic
4. Coordination with foreign and international organizations
5. Monitoring and evaluation
Strong leadership and support of the Government
Close co-operation between public health and animal health authorities, and among partners in multi – sectors
Proactive risk communication to the public and strong public involvement
Extensive international collaborations, especially with WHO, OIE, FAO, APEC,ASEAN-China-Korea-Japan,…
Existing infrastructure (surveillance, laboratories,
disease control, hospital infection, trained personnel)
Major success factors for AI control
The influenza epidemic of 1918 killed 20 million in just 18 months. With 25 million Americans alone infected during the influenza epidemic, it was hard to provide care for everyone. The Red Cross, seen here with masks over the faces of the nurses, often worked around the clock. Source: Courtesy of the National Library Museum.
CNN - “Businesses brace for pandemic”3 November 2005